LICENSE AGREEMENTLicense Agreement • September 9th, 2010 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
This LICENSE AGREEMENT (this “Agreement”) is made and entered into as of this 3rd day of May, 2010 (“Effective Date”) by and between Peregrine Pharmaceuticals, Inc., organized under the laws of Delaware, having its principal place of business at 14282 Franklin Avenue, Tustin, CA 92780 (“Licensor”), and Stason Pharmaceuticals, Inc., organized under the laws of California, having its principal place of business at 11 Morgan, Irvine, California 92618-4327 (“Licensee”). Licensor and Licensee may each be referred to herein individually as a “Party” and collectively as the “Parties.”
ASSIGNMENT AGREEMENTAssignment Agreement • September 9th, 2010 • Peregrine Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • California
This ASSIGNMENT AGREEMENT (this “Agreement”) is made and entered into as of this 3rd day of May 2010 (“Effective Date”) by and between Peregrine Pharmaceuticals, Inc., organized under the laws of Delaware, having its principal place of business at 14282 Franklin Avenue, Tustin, CA 92780 (“Seller”), and Stason Pharmaceuticals, Inc., organized under the laws of California, having its principal place of business at 11 Morgan, Irvine, California 92618-4327 (“Purchaser”). Seller and Purchaser may each be referred to herein individually as a “Party” and collectively as the “Parties.”
